Page 4 - Thorac Oncol News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial

Icotinib versus chemotherapy as adjuvant treatment for stage II–IIIA EGFR-mutant non-small-cell lung cancer (EVIDENCE): a randomised, open-label, phase 3 trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South koreaJ thorac cardiovascZa zhiLe teuffEnglj medThorac cardiovasc surgLung adjuvant cisplatinThorac oncolClin oncolRespir medFei ai za zhiZhong liu za zhiதெற்கு கொரியாஜ ழிஃபெ ஐ ஜ ழி

Lung cancer

Lung cancer
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South koreaSwitzerland generalKyongsang namdoUnited statesUnited kingdomJapan generalComunidad autonoma de catalunaDiaz jrChen chaoWilliam jrBunn jrBernabe caroLe pechouxJ thorac cardiovascSemin thorac cardiovascAmerican society of clinical oncology

Daiichi Sankyo Company, Limited: Patritumab Deruxtecan Data at ASCO Demonstrates Tumor Response Across Multiple Resistance Mechanisms in Patients with Advanced EGFR-Mutated NSCLC

Oral presentation highlighting extended follow-up data from phase 1 study in patients with locally advanced or metastatic TKI-resistant, EGFR-mutated NSCLC shows promising clinical activity Data

South koreaUnited statesMasashi kawasePatritumab deruxtecanDaiichi sankyoDaiichi sankyo europe gmbSarah mcgovernDaiichi sankyo companyAmerican society of clinical oncologyOncology developmentEuropean society of medical oncologyDaiichi sankyo incVirtual scientific programThoracic oncology at dana farber cancer instituteWorld health organizationSustainable development of society

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials

Pembrolizumab with or without radiotherapy for metastatic non-small-cell lung cancer: a pooled analysis of two randomised trials
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

Englj medClin oncolCancer resClin investThorac oncolபுற்றுநோய் ரெஸ்கிளினிக் முதலீடு

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial

Cemiplimab monotherapy for first-line treatment of advanced non-small-cell lung cancer with PD-L1 of at least 50%: a multicentre, open-label, global, phase 3, randomised, controlled trial
thelancet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thelancet.com Daily Mail and Mail on Sunday newspapers.

South koreaBartin iliMoreno garciaNational comprehensive cancer networkRev clin oncolThorac disEnglj medClin oncolNatl acad sci united statesCancer therCancer resLung cancerThorac oncolPacj cancer prevதெற்கு கொரியாபார்டின் இழி